CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,641,362 | +4.5% | 9,681,818 | 0.0% | 0.97% | +2.3% |
| Q2 2023 | $59,930,453 | +60.8% | 9,681,818 | 0.0% | 0.94% | +118.2% |
| Q1 2023 | $37,274,999 | +24.2% | 9,681,818 | 0.0% | 0.43% | +9.1% |
| Q4 2022 | $30,013,636 | -22.9% | 9,681,818 | 0.0% | 0.40% | -13.3% |
| Q3 2022 | $38,921,000 | -17.5% | 9,681,818 | 0.0% | 0.46% | -25.6% |
| Q2 2022 | $47,150,000 | -45.7% | 9,681,818 | 0.0% | 0.62% | -22.4% |
| Q1 2022 | $86,846,000 | -20.3% | 9,681,818 | 0.0% | 0.79% | -5.6% |
| Q4 2021 | $109,017,000 | -32.6% | 9,681,818 | 0.0% | 0.84% | -11.2% |
| Q3 2021 | $161,686,000 | +385.3% | 9,681,818 | +545.5% | 0.95% | +301.3% |
| Q2 2021 | $33,315,000 | – | 1,500,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 17,923,892 | $299,329,000 | 65.12% |
| Vida Ventures Advisors, LLC | 3,931,818 | $65,661,000 | 18.81% |
| Samsara BioCapital, LLC | 1,537,533 | $25,677,000 | 4.03% |
| VR Adviser, LLC | 1,127,272 | $18,825,000 | 2.42% |
| Logos Global Management LP | 1,069,545 | $17,861,000 | 1.29% |
| Cormorant Asset Management, LP | 1,727,273 | $28,724,000 | 1.17% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $161,686,000 | 0.95% |
| Affinity Asset Advisors, LLC | 203,183 | $3,393,000 | 0.86% |
| RA Capital Management | 3,577,094 | $59,737,000 | 0.83% |
| Boxer Capital, LLC | 1,334,227 | $22,282,000 | 0.78% |